Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-02
DOI
10.1038/srep22388
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression
- (2015) Masao Saitoh CANCER SCIENCE
- Transforming growth factor-β stimulates human ovarian cancer cell migration by up-regulating connexin43 expression via Smad2/3 signaling
- (2015) Xin Qiu et al. CELLULAR SIGNALLING
- Modes of cancer cell invasion and the role of the microenvironment
- (2015) Andrew G Clark et al. CURRENT OPINION IN CELL BIOLOGY
- Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial–mesenchymal transition in cancer
- (2015) Nastaran Mohammadi Ghahhari et al. EUROPEAN JOURNAL OF CANCER
- New Wnt/β-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals
- (2015) Jingjing Qi et al. GUT
- Clinical Cancer Advances 2015: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
- (2015) Gregory A. Masters et al. JOURNAL OF CLINICAL ONCOLOGY
- Bioactivity-guided fast screen and identification of cancer metastasis chemopreventive components from raw extracts of Murraya exotica
- (2015) Zhou Jiang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Stable isotope labelling methods in mass spectrometry-based quantitative proteomics
- (2015) Osama Chahrour et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization
- (2015) C Hwangbo et al. ONCOGENE
- Epithelial–mesenchymal transition in human cancer: Comprehensive reprogramming of metabolism, epigenetics, and differentiation
- (2015) Linna Li et al. PHARMACOLOGY & THERAPEUTICS
- MYSM-1 suppresses migration and invasion in renal carcinoma through inhibiting epithelial-mesenchymal transition
- (2015) Lei Zhou et al. TUMOR BIOLOGY
- The role of taxanes in triple-negative breast cancer: literature review
- (2015) Giorgio Mustacchi et al. Drug Design Development and Therapy
- Efficacy and safety of capecitabine-based first-line chemotherapy in advanced or metastatic breast cancer: a meta-analysis of randomised controlled trials
- (2015) Weijiao Yin et al. Oncotarget
- Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways
- (2015) Yi-Hua Lai et al. Oncotarget
- EMT, CTCs and CSCs in tumor relapse and drug-resistance
- (2015) Abhisek Mitra et al. Oncotarget
- Systems pharmacology of mifepristone (RU486) reveals its 47 hub targets and network: Comprehensive analysis and pharmacological focus on FAK-Src-Paxillin complex
- (2015) Suhong Yu et al. Scientific Reports
- TGFβSignaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis
- (2015) Panagiotis Papageorgis Journal of Oncology
- Epithelial to Mesenchymal Transition in a Clinical Perspective
- (2015) Jennifer Pasquier et al. Journal of Oncology
- Synthesis, Spectral Characterization, and In Vitro Cellular Activities of Metapristone, a Potential Cancer Metastatic Chemopreventive Agent Derived from Mifepristone (RU486)
- (2014) Jichuang Wang et al. AAPS Journal
- Metabolic fingerprinting based on high-resolution tandem mass spectrometry: a reliable tool for wine authentication?
- (2014) Josep Rubert et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MUC1 drives epithelial–mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter
- (2014) Viviane Gnemmi et al. CANCER LETTERS
- Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratioviaAIB1 or SMRT recruitment to theCCND1andMYCpromoters
- (2014) Victoria Wargon et al. INTERNATIONAL JOURNAL OF CANCER
- A novel UPLC/MS/MS method for rapid determination of metapristone in rat plasma, a new cancer metastasis chemopreventive agent derived from mifepristone (RU486)
- (2014) Jian-Zhong Chen et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer Metastasis
- (2014) Jianzhong Chen et al. MEDICINAL RESEARCH REVIEWS
- Caveolin-1 regulates metastatic behaviors of anoikis resistant lung cancer cells
- (2014) Pithi Chanvorachote et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Caveolin-1 Is Up-Regulated by GLI1 and Contributes to GLI1-Driven EMT in Hepatocellular Carcinoma
- (2014) Xiaohong Gai et al. PLoS One
- The minimal cadherin-catenin complex binds to actin filaments under force
- (2014) C. D. Buckley et al. SCIENCE
- Signaling mechanisms of the epithelial-mesenchymal transition
- (2014) D. M. Gonzalez et al. Science Signaling
- Nitric Oxide Inhibits Hetero-adhesion of Cancer Cells to Endothelial Cells: Restraining Circulating Tumor Cells from Initiating Metastatic Cascade
- (2014) Yusheng Lu et al. Scientific Reports
- Molecular Biomarkers of Cancer Stem/Progenitor Cells Associated with Progression, Metastases, and Treatment Resistance of Aggressive Cancers
- (2013) M. Mimeault et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition
- (2013) Anbarasu Kannan et al. EUROPEAN JOURNAL OF CANCER
- Pharmacoproteomic Study of the Natural Product Ebenfuran III in DU-145 Prostate Cancer Cells: The Quantitative and Temporal Interrogation of Chemically Induced Cell Death at the Protein Level
- (2013) Theodoros I. Roumeliotis et al. JOURNAL OF PROTEOME RESEARCH
- Comparative Analysis of Dynamic Proteomic Profiles between in Vivo and in Vitro Produced Mouse Embryos during Postimplantation Period
- (2013) Jingzhou Nie et al. JOURNAL OF PROTEOME RESEARCH
- Novel mechanism regulating endothelial permeability via T-cadherin-dependent VE-cadherin phosphorylation and clathrin-mediated endocytosis
- (2013) Ekaterina V. Semina et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Crosstalk between breast cancer stem cells and metastatic niche: emerging molecular metastasis pathway?
- (2013) Hassan Fazilaty et al. TUMOR BIOLOGY
- Withaferin-A Reduces Type I Collagen Expression In Vitro and Inhibits Development of Myocardial Fibrosis In Vivo
- (2012) Azariyas A. Challa et al. PLoS One
- Model-based gene set analysis for Bioconductor
- (2011) S. Bauer et al. BIOINFORMATICS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pharmacoproteomic Analysis of a Novel Cell-permeable Peptide Inhibitor of Tumor-induced Angiogenesis
- (2011) Ji-Young Bang et al. MOLECULAR & CELLULAR PROTEOMICS
- Transforming Growth Factor-β (TGFβ) Receptors I/II Differentially Regulate TGFβ1 and IGF-Binding Protein-3 Mitogenic Effects in the Human Placenta
- (2010) Karen Forbes et al. ENDOCRINOLOGY
- Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer
- (2010) K Vuoriluoto et al. ONCOGENE
- Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression
- (2009) Kai-jie Wu et al. ACTA PHARMACOLOGICA SINICA
- Decreased expression of glutaredoxin 1 is required for transforming growth factor-β1-mediated epithelial–mesenchymal transition of EpRas mammary epithelial cells
- (2009) Eun Kyung Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LY2109761, a novel transforming growth factor receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
- (2008) D. Melisi et al. MOLECULAR CANCER THERAPEUTICS
- TGF-β-mediated activation of RhoA signalling is required for efficient V12HaRas and V600EBRAF transformation
- (2008) Y M Fleming et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started